Clinical Trial Update: CARE Canadian ALS Riluzole Evaluation [Phase 4]

View source ↗

Summary

The CARE Canadian ALS Riluzole Evaluation trial, a Phase 4 study of riluzole in amyotrophic lateral sclerosis, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: Sanofi | Conditions: Amyotrophic Lateral Sclerosis | Phase 4 | Status: COMPLETED